Accelrys Buys Chemsw In Deal Worth Up To $17.

By obtaining ChemSW, Accelrys said, it can offers clients an automated inventory system that monitors and tracks location and quantity specifics, monitors usage, generates reviews, and assesses hazard information during emergencies. The operational system is available both on premises and via cloud computing. Accelrys also stated its customers can use ChemSW's EH&S software to help support their sustainability attempts by addressing three essential areas: improving operational performance, delivering innovation, and conference compliance requirements. Related StoriesMedUni Vienna researchers discover genetic cause of a uncommon diseaseStudy uncovers fresh genetic variants linked to increased risk of testicular cancerGenetic reduced amount of AMPK enzyme can prevent or delay hearing lossAccelrys agreed to acquire all ChemSW shares for $15.3 million, then spend up to $2 million to unspecified ChemSW executives linked with undisclosed operating milestones through the first two years following day of the closing.'Our wish is that by monitoring and publicly reporting these procedures we can raise awareness of variation where it exists and help to ensure consistent, evidence-based care is provided across the U.S.' said ACC President Kim Allan Williams, M.D., FACC. 'The hospitals that voluntarily chose to participate in this open public reporting work are showing a genuine dedication to quality improvement and assisting to ensure cardiovascular disease patients nationwide have the best possible care.' Hospitals can receive up to four superstars based on their functionality in each data measure with four out of four being the highest ranking; hospitals that chose never to discharge data are listed as not taking part in ACC's open public reporting effort..